Overview

Study to Compare the Pharmacokinetics of a Dexamethasone Iontophoretic Patch to a Dexamethasone Injection

Status:
Unknown status
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The primary objectives are to evaluate the extent of systemic exposure and dexamethasone bioavailability following a single application of a dexamethasone iontophoretic transdermal patch in healthy volunteers. The secondary objectives are to evaluate the systemic and topical safety of the dexamethasone iontophoretic transdermal patch and of the dexamethasone intramuscular (IM) injection.
Phase:
Phase 1
Details
Lead Sponsor:
Travanti Pharma Inc.
Collaborator:
Cetero Research, San Antonio
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate